Davoceticept Biosimilar – Anti-CTLA-4, PD-L1, CD28 fusion protein – Research Grade

Reference:
Product nameDavoceticept Biosimilar - Anti-CTLA-4, PD-L1, CD28 fusion protein - Research Grade
Expression systemXtenCHO
Purity>90% by SDS-PAGE.
Buffer0.01M PBS, pH 7.4.
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
ApplicationsELISA,WB
Aliases /Synonymsanti-CTLA-4, PD-L1, CD28
ReferencePX-TA2009
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeFusion - [CD80 (B7-1, CD28LG1) fragment (1-107)]2 - IGHG1 Fc (Fragment constant)

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Davoceticept Biosimilar – Anti-CTLA-4, PD-L1, CD28 fusion protein – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Tumor-associated calcium signal transducer 2(TACSTD2)
Antigen

Tumor-associated calcium signal transducer 2(TACSTD2)

PX-P4569 210€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products